Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (17)

2024

  1. Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  2. Molecular and Cellular Characterization of Primary Endothelial Cells from a Familial Cavernomatosis Patient

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

2023

  1. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth

    Acta Neurochirurgica, Vol. 165, Núm. 12, pp. 4241-4251

2022

  1. A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  2. Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  3. The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases

    International Journal of Molecular Sciences, Vol. 23, Núm. 8

2020

  1. CLN5 in heterozygosis may protect against the development of tumors in a VHL patient

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  2. Review of pharmacological strategies with repurposed drugs for hereditary hemorrhagic telangiectasia related bleeding

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-22

  3. Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30

2019

  1. Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: Phase III clinical trial

    BMJ Open Ophthalmology, Vol. 4, Núm. 1

  2. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease

    Scientific Reports, Vol. 9, Núm. 1

  3. c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch

    Stem Cells, Vol. 37, Núm. 8, pp. 1108-1118

2013

  1. Glucagon regulation of oxidative phosphorylation requires an increase in matrix adenine nucleotide content through Ca2+ activation of the mitochondrial ATP-Mg/Pi carrier SCaMC-3

    Journal of Biological Chemistry, Vol. 288, Núm. 11, pp. 7791-7802

2012

  1. C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, Núm. 8, pp. 1366-1377

2009

  1. p53 regulates the self-renewal and differentiation of neural precursors

    Neuroscience, Vol. 158, Núm. 4, pp. 1378-1389

2007

  1. Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

    Apoptosis, Vol. 12, Núm. 9, pp. 1733-1742

  2. p38α MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum

    FEBS Letters, Vol. 581, Núm. 20, pp. 3819-3825